These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 6223736)
1. The effects of intravenous pulse methylprednisolone on immunological and inflammatory processes in ankylosing spondylitis. Richter MB; Woo P; Panayi GS; Trull A; Unger A; Shepherd P Clin Exp Immunol; 1983 Jul; 53(1):51-9. PubMed ID: 6223736 [TBL] [Abstract][Full Text] [Related]
2. [Effectiveness of pulse-therapy in seronegative spondyloarthritis (preliminary report)]. Burdeĭnyĭ AP; Solov'ev SK; Timofeeva EB Ter Arkh; 1987; 59(4):84-6. PubMed ID: 3590010 [TBL] [Abstract][Full Text] [Related]
3. Intravenous methylprednisolone pulse therapy in ankylosing spondylitis. Ejstrup L; Peters ND Dan Med Bull; 1985 Aug; 32(4):231-3. PubMed ID: 4042697 [TBL] [Abstract][Full Text] [Related]
4. Is there more than one signal for an acute phase response? Richter MB; Coughlan RJ; Panayi GS; Gordon Y J Rheumatol; 1985 Dec; 12(6):1048-52. PubMed ID: 2419556 [TBL] [Abstract][Full Text] [Related]
5. A case of HLA-B27 negative ankylosing spondylitis treated with methylprednisolone pulse therapy. Yoshida S; Motai Y; Hattori H; Yoshida H; Torikai K J Rheumatol; 1993 Oct; 20(10):1805-6. PubMed ID: 8295202 [No Abstract] [Full Text] [Related]
6. The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. II. Effects on immune and inflammatory indices in peripheral blood. Smith MD; Ahern MJ; Brooks PM; Roberts-Thomson PJ J Rheumatol; 1988 Feb; 15(2):233-7. PubMed ID: 3361535 [TBL] [Abstract][Full Text] [Related]
7. A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate. Malaviya AN; Kapoor S; Garg S; Ahmad I; Raja RR J Assoc Physicians India; 2007 Mar; 55():193-7. PubMed ID: 17598330 [TBL] [Abstract][Full Text] [Related]
9. [Intravenous high dose glucocorticoids in patients with ankylosing spondylitis]. Rumiantseva OA; Bochkova AG; Liginova EIu; Kiseleva NM; Pushkova OV; Bunchuk NV Ter Arkh; 2006; 78(12):71-5. PubMed ID: 17294868 [TBL] [Abstract][Full Text] [Related]
10. Effect of corticosteroids on the human immune response: comparison of one and three daily 1 gm intravenous pulses of methylprednisolone. Fan PT; Yu DT; Clements PJ; Fowlston S; Eisman J; Bluestone R J Lab Clin Med; 1978 Apr; 91(4):625-34. PubMed ID: 76667 [TBL] [Abstract][Full Text] [Related]
11. Effects of intravenous methylprednisolone on mixed lymphocyte cultures in normal humans. Cheigh JS; Stenzel KH; Riggio RR; Katz EB; Rubin AL Transplant Proc; 1975 Mar; 7(1):31-5. PubMed ID: 123374 [TBL] [Abstract][Full Text] [Related]
12. Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis. Calin A; Dijkmans BA; Emery P; Hakala M; Kalden J; Leirisalo-Repo M; Mola EM; Salvarani C; Sanmartí R; Sany J; Sibilia J; Sieper J; van der Linden S; Veys E; Appel AM; Fatenejad S Ann Rheum Dis; 2004 Dec; 63(12):1594-600. PubMed ID: 15345498 [TBL] [Abstract][Full Text] [Related]
13. CD4+ and CD8+ lymphocyte and cortisol response patterns in elderly and young males after methylprednisolone exposure. Tornatore KM; Venuto RC; Logue G; Davis PJ J Med; 1998; 29(3-4):159-83. PubMed ID: 9865456 [TBL] [Abstract][Full Text] [Related]
14. The use of methylprednisolone pulse therapy in a severe case of HLA-B27 negative ankylosing spondylitis. Mercado U J Rheumatol; 1994 Aug; 21(8):1582-3. PubMed ID: 7983673 [No Abstract] [Full Text] [Related]
15. [Clinical study of etanercept for treating ankylosing spondylitis]. Liang LQ; Zhan ZP; Ye YJ; Fu D; Xu HS; Yang XY Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1349-51. PubMed ID: 18753057 [TBL] [Abstract][Full Text] [Related]
16. Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease. Mathieu S; Joly H; Baron G; Tournadre A; Dubost JJ; Ristori JM; Lusson JR; Soubrier M Rheumatology (Oxford); 2008 Aug; 47(8):1203-7. PubMed ID: 18524805 [TBL] [Abstract][Full Text] [Related]
17. A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment. Durez P; Nzeusseu Toukap A; Lauwerys BR; Manicourt DH; Verschueren P; Westhovens R; Devogelaer JP; Houssiau FA Ann Rheum Dis; 2004 Sep; 63(9):1069-74. PubMed ID: 15308515 [TBL] [Abstract][Full Text] [Related]
18. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis]. Yang CH; Huang F; Deng XH; Zhang JL; Zhang LY; Guo JH; Liang DF; Wang LS; Zhang YM Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2451-4. PubMed ID: 17156669 [TBL] [Abstract][Full Text] [Related]
19. Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study. Joshi SS; Bishop MR; Lynch JC; Tarantolo SR; Abhyankar S; Bierman PJ; Vose JM; Geller RB; McGuirk J; Foran J; Bociek RG; Hadi A; Day SD; Armitage JO; Kessinger A; Pavletic ZS Cytotherapy; 2003; 5(6):542-52. PubMed ID: 14660050 [TBL] [Abstract][Full Text] [Related]
20. [Cellular immunity during ankylosing spondylitis]. Sany J; Clot J; Andary M Rev Rhum Mal Osteoartic; 1980 Jun; 47(6):403-8. PubMed ID: 7455598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]